Novel Coronavirus SARS-CoV-2, from the National Institute of Allergy and Infectious Diseases (NIAID). Virologists and Lung Disease Specialists Commission Bruker´s Micro-CT for some of the World’s First in vivo COVID-19 Imaging Experiments Reprinted from the Lab Bulletin: Jul 27, 2020 | author/source: Bruker Corporation Bruker’s BioSpin PreClinical Imaging Division
- Ann Bagnell